期刊文献+

输尿管软镜下钬激光内切开引流术治疗肾囊性病变的可行性

Feasibility of Holmium laser drainage under flexible ureteroscope in the treatment of renal cystic diseases
在线阅读 下载PDF
导出
摘要 目的探讨输尿管软镜下钬激光内切开引流术治疗肾囊性病变的可行性。方法选取我院2018年3月24日~2019年6月25日收治的40例肾囊性病变患者作为研究对象,按照随机数字表法分为观察组(20例)与对照组(20例)。观察组采用输尿管软镜下钬激光内切开引流术治疗方法 ,对照组采用腹腔镜囊肿去顶减压术治疗方法。比较两组的手术情况、血红蛋白下降值、血肌酐升高值、并发症总发生率。结果观察组的手术时间、术后肠道恢复时间、术后住院时间、术后下床活动时间均短于对照组,术中出血量少于对照组差异有统计学意义(P<0.05);观察组的血红蛋白下降值、血肌酐升高值均低于对照组,差异有统计学意义(P<0.05);观察组的并发症总发生率为5.00%,低于对照组的30.00%,差异有统计学意义(P<0.05)。结论输尿管软镜下钬激光内切开引流术治疗肾囊性病变的可行性较好,可缩短手术时间,降低并发症发生率,能够促进患者康复,值得临床推广。 Objective To explore the feasibility of Holmium laser drainage under flexible ureteroscope in the treatment of renal cystic diseases.Methods A total of 40 patients with renal cystic diseases treated in our hospital from March 24,2018 to June 25,2019 were selected as the research subjects.They were divided into the observation group(n=20)and the control group(n=20)according to the random number table method.In the observation group,Holmium laser drainage under flexible ureteroscope was used,and in the control group,laparoscopic cyst windowing decompression was applied.The surgical conditions,the decrease of hemoglobin,the increase of serum creatinine,and the total incidence of complications were compared between the two groups.Results In the observation group,the operation time,postoperative intestinal recovery time,postoperative hospital stay,postoperative time of getting out of bed were all shorter than those of the control group,and the differences were statistically significant(P<0.05).In the observation group,the hemoglobin decreased value,intraoperative blood loss less than that of the control group,and the serum creatinine increased value were both lower than those of the control group,with statistical significance(P<0.05).The total incidence of complications in the observation group was 5.00%,which was lower than that of the control group accounting for 30.00%,with significant difference(P<0.05).Conclusion Holmium laser drainage under flexible ureteroscope has good feasibility in treating renal cystic lesions.It can shorten the operation time,reduce the incidence of complications,and promote patient′s rehabilitation,which is worthy of clinical promotion.
作者 黄水通 吴爱明 黎志钦 HUANG Shui-tong;WU Ai-ming;LI Zhi-qin(The Second Department of Urology,Maoming People′s Hospital,Guangdong Province,Maoming 525000,China)
出处 《中国当代医药》 2020年第16期92-94,共3页 China Modern Medicine
基金 广东省茂名市科技计划项目(180324181700500)。
关键词 输尿管软镜 钬激光 肾囊性病变 血肌酐 Flexible ureteroscope Holmium laser Renal cystic disease Serum creatinine
  • 相关文献

参考文献10

二级参考文献64

  • 1Chapman AB, Devuyst O, Eckardt KU, et al. Autosomal- dominant polycystic kidney disease (ADPKD) :executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference[J]. Kidney Int, 2015,88 ( 1 ) : 17-27.
  • 2Pei Y, Watnick T. Diagnosis and screening of autosomal dominant polycystic kidney disease[ J]. Adv Chronic Kidney Dis, 2010, 17 (2) :140-152.
  • 3Rossetti S, Consugar MB, Chapman AB, et al. Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease[J]. J Am Soc Nephrol, 2007, 18(7) :2143-2160.
  • 4Irazabal MV, Rangel LJ, Bergstralh E J, et al. Imaging classification of ADPKD:a simple model for selecting patients for clinical trials[J]. J Am Soc Nephrol, 2015, 26( 1 ) : 160-172.
  • 5Chapman A, Johnson A, Gabow P, et al. Overt proteinuria anti microalbuminuria in autosomal dominant polycystic kidney disease [J]. JAmSocNephrol, 1994, 5(6) :1349-1354.
  • 6Kidney Disease: hnproving Global Outcomes ( KDIGO ) Blood Pressure Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease [ J]. Kidney Int Suppl, 2012, 2(5) :337-414.
  • 7Kidney Disease: Improving Global Outcomes ( KDIGO ) CKD Work Group. KD1GO clinical practice guideline for the evaluation and management of chronic kidney disease [ J ]. Kidney Int Suppl, 2013, 3(1) :1-150.
  • 8Schrier RW. Hypertension and autosomal dominant polycystic kidney disease[J]. Am J Kidney Dis, 2011, 57(6) :811-813.
  • 9Schrier RS, Abebe KZ, Perrone RD, et al. Blood pressure in early autosomal dominant polycystic kidney disease [ J ]. N Engl J Meal, 2014, 371 ( 24 ): 2255-2266.
  • 10Tortes VE, Abebe KZ, Chapman AB, et al. Angiotensin blockade in late autosomal dominant polycystit: kidney disease J ]. N Engl J Med, 2014, 371 (24) :2267-2276.

共引文献102

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部